COMPASS PATHWAYS PLC

NASDAQ: CMPS (COMPASS Pathways Plc - American)

Kemas kini terakhir: 03 May, 8:50PM

4.19

0.09 (2.20%)

Penutupan Terdahulu 4.10
Buka 4.12
Jumlah Dagangan 628,483
Purata Dagangan (3B) 1,068,862
Modal Pasaran 389,039,424
Harga / Buku (P/B) 1.69
Julat 52 Minggu
2.49 (-40%) — 9.63 (129%)
Tarikh Pendapatan 8 May 2025
EPS Cair (TTM) -1.99
Jumlah Hutang/Ekuiti (D/E MRQ) 16.39%
Nisbah Semasa (MRQ) 10.18
Aliran Tunai Operasi (OCF TTM) -144.02 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -96.01 M
Pulangan Atas Aset (ROA TTM) -32.40%
Pulangan Atas Ekuiti (ROE TTM) -60.62%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Care Facilities (US) Bercampur Menurun
Medical Care Facilities (Global) Bercampur Menurun
Stok COMPASS Pathways Plc - American Menaik Menurun

AISkor Stockmoo

0.5
Konsensus Penganalisis 5.0
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal -1.0
Purata 0.50

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
CMPS 389 M - - 1.69
AONC 381 M - - -
BMGL 20 M - 11.33 7.45
PAIYY 10 M - - 2.41
NIVF 4 M - - 7.15
PIIIW - - - -

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Sektor Healthcare
Industri Medical Care Facilities
% Dimiliki oleh Orang Dalam 13.64%
% Dimiliki oleh Institusi 56.03%
130.80130.8098.4098.4066.0066.0033.6033.601.201.20Harga Sasaran MedianQ4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25Q3 '25Q3 '25
Julat 52 Minggu
2.49 (-40%) — 9.63 (129%)
Julat Harga Sasaran
6.00 (43%) — 45.00 (973%)
Tinggi 45.00 (HC Wainwright & Co., 973.99%) Beli
Median 12.00 (186.40%)
Rendah 6.00 (Evercore ISI Group, 43.20%) Pegang
Purata 21.00 (401.19%)
Jumlah 2 Beli, 1 Pegang
Harga Purata @ Panggilan 3.45
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
HC Wainwright & Co. 15 Jul 2025 45.00 (973.99%) Beli 3.72
12 May 2025 45.00 (973.99%) Beli 3.91
Evercore ISI Group 23 Jun 2025 6.00 (43.20%) Pegang 2.35
Cantor Fitzgerald 27 May 2025 12.00 (186.40%) Beli 4.28

Tiada data dalam julat masa ini.

3.933.933.483.483.023.022.572.572.112.11Jun 30Jun 30Jul 1Jul 1Jul 2Jul 2Jul 3Jul 3Jul 7Jul 7Jul 8Jul 8Jul 9Jul 9Jul 10Jul 10

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.1000.100-0.000-0.000-0.100-0.100-0.200-0.200-0.300-0.300MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda